These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28612364)

  • 1. Successful treatment with placenta-derived decidual stromal cells in a pediatric patient with life-threatening acute gastrointestinal graft-versus-host disease.
    Gustafsson B; Frisk P; Szakos A; Sadeghi B; Ringdén O; Frost BM
    Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28612364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease.
    Ringden O; Baygan A; Remberger M; Gustafsson B; Winiarski J; Khoein B; Moll G; Klingspor L; Westgren M; Sadeghi B
    Stem Cells Transl Med; 2018 Apr; 7(4):325-331. PubMed ID: 29533533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended Treatment With Mesenchymal Stromal Cells-Frankfurt am Main in a Pediatric Patient With Steroid-refractory Acute Gastrointestinal Graft-Versus-Host Disease: Case Report and Review of the Literature.
    Gruhn B; Brodt G; Ernst J
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):e419-e425. PubMed ID: 32118816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal acute graft-versus-host disease in children: histology for diagnosis, mesenchymal stromal cells for treatment, and biomarkers for prediction of response.
    Calkoen FG; Jol-van der Zijde CM; Mearin ML; Schweizer JJ; Jansen-Hoogendijk AM; Roelofs H; van Halteren AG; Egeler RM; van Tol MJ; Ball LM
    Biol Blood Marrow Transplant; 2013 Nov; 19(11):1590-9. PubMed ID: 23994245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients.
    Kurtzberg J; Prockop S; Teira P; Bittencourt H; Lewis V; Chan KW; Horn B; Yu L; Talano JA; Nemecek E; Mills CR; Chaudhury S
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):229-35. PubMed ID: 24216185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Follow-Up After the Application of Mesenchymal Stromal Cells in Children and Adolescents with Steroid-Refractory Graft-Versus-Host Disease.
    Döring M; Cabanillas Stanchi KM; Lenglinger K; Treuner C; Gieseke F; Erbacher A; Mezger M; Vaegler M; Schlegel PG; Greil J; Bettoni da Cunha Riehm C; Faul C; Schumm M; Lang P; Handgretinger R; Müller I
    Stem Cells Dev; 2021 Mar; 30(5):234-246. PubMed ID: 33446053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Role of Gastrointestinal Endoscopy in the Management of Gastrointestinal Acute GVHD in Children After Hematopoietic Stem Cell Transplantation.
    Gassas A; Krueger J; Schechter T; Zaidman I; Asim M; Ali M
    J Pediatr Hematol Oncol; 2016 Aug; 38(6):453-6. PubMed ID: 27164524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Chen X; Wang C; Yin J; Xu J; Wei J; Zhang Y
    PLoS One; 2015; 10(8):e0136991. PubMed ID: 26323092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal membrane cells for treatment of steroid-refractory acute graft-versus-host disease.
    Ringdén O; Erkers T; Nava S; Uzunel M; Iwarsson E; Conrad R; Westgren M; Mattsson J; Kaipe H
    Stem Cells; 2013 Mar; 31(3):592-601. PubMed ID: 23307526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical characteristics of acute graft-versus-host disease confined solely to gastrointestinal tract after allogeneic hematopoietic stem cell transplantation].
    Feng R; Liu DH; Xu LP; Chen H; Zhang XH; Han W; Zhao T; Liu KY; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2010 Dec; 49(12):1028-31. PubMed ID: 21211361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and unmet needs in steroid-refractory acute graft-versus-host disease.
    Malard F; Huang XJ; Sim JPY
    Leukemia; 2020 May; 34(5):1229-1240. PubMed ID: 32242050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey.
    Kuçi Z; Bönig H; Kreyenberg H; Bunos M; Jauch A; Janssen JW; Škifić M; Michel K; Eising B; Lucchini G; Bakhtiar S; Greil J; Lang P; Basu O; von Luettichau I; Schulz A; Sykora KW; Jarisch A; Soerensen J; Salzmann-Manrique E; Seifried E; Klingebiel T; Bader P; Kuçi S
    Haematologica; 2016 Aug; 101(8):985-94. PubMed ID: 27175026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation.
    Dotoli GM; De Santis GC; Orellana MD; de Lima Prata K; Caruso SR; Fernandes TR; Rensi Colturato VA; Kondo AT; Hamerschlak N; Simões BP; Covas DT
    Bone Marrow Transplant; 2017 Jun; 52(6):859-862. PubMed ID: 28287644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute gastrointestinal graft-versus-host disease in pediatric patients: serum albumin on day 5 from initiation of therapy correlates with nonrelapse mortality and overall survival.
    Goussetis E; Paisiou A; Kitra V; Peristeri I; Vessalas G; Stefanaki K; Panayotou I; Giamaiou K; Kontou E; Kitzoni M; Dimopoulou MN; Karkelis S; Kafritsa Y; Rapsomaniki E; Papassotiriou I; Tsirigotis P; Roma E; Graphakos S
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1058-66. PubMed ID: 21073975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel therapies for graft versus host disease with a focus on cell therapies.
    Zeiser R; Ringden O; Sadeghi B; Gonen-Yaacovi G; Segurado OG
    Front Immunol; 2023; 14():1241068. PubMed ID: 37868964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Curative effect of human umbilical cord mesenchymal stem cells for treatment of acute graft-versus-host disease of children after allo-HSCT].
    Qiao SM; Chen GH; Wang Y; Hu SY; Sun XD; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):716-20. PubMed ID: 23815929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placenta-Derived Decidua Stromal Cells: A New Frontier in the Therapy of Acute Graft-Versus-Host Disease.
    Ringdén O; Sadeghi B
    Stem Cells; 2024 Apr; 42(4):291-300. PubMed ID: 38204331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation.
    Khandelwal P; Emoto C; Fukuda T; Vinks AA; Neumeier L; Dandoy CE; El-Bietar J; Chandra S; Davies SM; Bleesing JJ; Jordan MB; Mehta PA; Jodele S; Grimley MS; Kumar A; Myers KC; Marsh RA
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2220-2225. PubMed ID: 27664325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.